Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome | Clinical Trials | Clareo Health

Back to search

TERMINATEDPhase 4

Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome

NCT04668859•Medstar Health Research Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Use of Midodrine in Post-cardiopulmonary Bypass Vasoplegic Syndrome

Interventions

Midodrine

Methylcellulose

Key Dates

Start Date

July 29, 2016

Primary Completion Date

August 8, 2018

Completion Date

August 8, 2018

Last Updated

July 1, 2022

Sponsors

Lead Sponsor

Medstar Health Research Institute

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 1, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions